Yeast Two-Hybrid Screening for Ligand Binding

Yeast two-hybrid · In vivo screening · False positives · GPCR variants

Published 2026 · Last updated 2026-09-28 · Hailu Zhou

What question does this answer? Can the water-soluble variant still bind its ligand inside a living cell? Once sequence analysis confirms the transmembrane helices survive substitution, the next question is whether the redesigned protein still recognises its partner. The yeast two-hybrid system asks this inside a living eukaryotic cell, and it is the first step in the pipeline that reports an actual interaction rather than a predicted one.

The genetic principle

The yeast two-hybrid (Y2H) system was introduced by Fields and Song in 1989 [1]. It exploits the modular nature of a eukaryotic transcription factor: the DNA-binding domain (BD) and the activation domain (AD) can be separated and placed on two different proteins. Neither half alone drives transcription. If, however, the two proteins fused to BD and AD physically associate, they bring the two domains into proximity, reconstitute a functional transcription factor, and switch on a reporter gene.

In the classic configuration the readout is nutritional. Yeast auxotrophic for histidine, adenine, or leucine survive on dropout medium (for example SD–Leu–Trp–His) only when the reporter is expressed, so growth itself is the signal. A second, colour-based reporter such as lacZ or ADE2 provides an orthogonal readout to confirm that growth is not merely a background effect. The bait is the receptor-derived construct fused to the DNA-binding domain; the prey is the ligand fused to the activation domain.

Why an in vivo screen is worth doing first

Y2H has two properties that make it an attractive opening assay. First, it is sensitive: because the reporter amplifies a weak interaction into a growth phenotype, proteins with modest affinity still give a signal. Second, it is performed in a living eukaryotic cell at physiological temperature and pH, in a reducing cytoplasmic environment with its own chaperones and quality-control machinery. If the variant receptor still engages its ligand there, the interaction is not an artefact of a purified, possibly denatured, tube preparation.

It is also fast and cheap relative to protein purification, which is precisely why it precedes the biochemical steps. A negative result at this stage saves the substantial effort of expressing and purifying a construct that cannot bind.

The cytoplasmic-environment compromise

A GPCR is a membrane protein, yet in Y2H the bait is expressed in the cytoplasm of the yeast cell. For a wild-type receptor this would be a hostile place, and the protein might misfold or aggregate. For a QTY variant, however, the design intent is exactly this: by replacing L/I/V/F with T/Q/Y, the protein is meant to be soluble in an aqueous, detergent-free environment. The cytoplasm is therefore not an accidental choice but a natural test of the design premise.

There is an important interpretive consequence. If the variant binds its ligand in the cytoplasm, we may conclude that the binding pocket and the surrounding extracellular-loop architecture are retained — the epitope recognised by the ligand has survived both the substitution and the transfer into water. What we may not conclude is anything about strength. The assay reports a yes or no; it cannot report how tightly.

The key limitation

Y2H is qualitative only. The growth phenotype is a threshold event: once interaction exceeds the detection limit, the colony grows, and further increases in affinity do not produce more growth in a linear or interpretable way. Affinity constants cannot be extracted. Consequently the second half of the pipeline's question — with what affinity? — must be answered by a biophysical method. Microscale thermophoresis (MST) provides the quantitative dissociation constant, fitting the change in thermophoretic mobility of a fluorescently labelled receptor across a ligand gradient to yield a Kd [2,3]. Y2H and MST are therefore complementary, not redundant: the first rules in a binding event, the second measures it.

Troubleshooting and pitfalls

Where this fits in the pipeline

Y2H rules out the second class of artefact: a variant that has the right architecture but has lost its binding function. It is sensitive and physiological, and it converts the computational claim of the previous step into experimental evidence. But because it yields no number, the construct that passes must move on to purification and quantitative measurement — the subject of the next stage.

References

  1. Fields S, Song O. A novel genetic system to detect protein–protein interactions. Nature. 1989;340(6230):245–246. doi:10.1038/340245a0
  2. Jerabek-Willemsen M, André T, Wanner R, et al. MicroScale Thermophoresis: interaction analysis and beyond. J Mol Struct. 2014;1077:101–113. doi:10.1016/j.molstruc.2014.03.009
  3. Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. Nat Commun. 2010;1:100. doi:10.1038/ncomms1093
  4. Seidel SAI, Dijkman PM, Lea WA, et al. Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. Methods. 2013;59(3):301–315. doi:10.1016/j.ymeth.2012.12.005
  5. Zhang S, Tao F, Qing R, et al. QTY code enables design of detergent-free chemokine receptors that retain ligand-binding activities. Proc Natl Acad Sci USA. 2018;115(37):E8652–E8659. doi:10.1073/pnas.1811031115
  6. Pándy-Szekeres G, Munk C, Tsonkov TM, et al. GPCRdb in 2018: adding GPCR structure models and ligands. Nucleic Acids Res. 2018;46(D1):D440–D446. doi:10.1093/nar/gkx1109
  7. Greenfield NJ. Using circular dichroism spectra to estimate protein secondary structure. Nat Protoc. 2006;1(6):2876–2890. doi:10.1038/nprot.2006.202